A long-acting flea and tick treatment from Merck Animal Health has earned approval for dogs at least six months old from the ...

FDA approves Bravecto Quantum, the first injectable flea and tick treatment offering dogs up to 12 months of protection.

Merck's animal health division received Food and Drug Administration approval for its once-yearly injectable flea-and-tick treatment for dogs. Merck Animal Health said Thursday it expects its Bravecto ...

Bravecto Quantum, a breakthrough, long-acting flea and tick treatment and preventative for dogs, will be available soon.

The U.S. Food and Drug Administration has given the green light to Bravecto Quantum, the first-ever flea and tick preventative that can protect dogs for up to 12 months with a single injection. The ...

Merck's animal health division received Food and Drug Administration approval for its once-yearly injectable flea-and-tick treatment for dogs. Merck Animal Health said Thursday it expects its ...

New treatment offers dogs year-round protection with a single shot.

Dogs across the U.S. could soon get longer-lasting protection against pesky parasites thanks to a new treatment approved by federal regulators Thursday. The U.S. Food and Drug Administration has given ...

BRAVECTO QUANTUM is also indicated for the treatment and control of Amblyomma americanum (lone star tick) infestations for 8 months in dogs and puppies 6 months of age and older.

The injectable treatment must be administered by a licensed veterinarian, who will determine whether an 8- or 12-month protection period is appropriate based on local tick species.